{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T01:41:05Z","timestamp":1661478065428},"reference-count":20,"publisher":"Georg Thieme Verlag KG","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Was ist neu?<\/jats:title><jats:p>\n          \u00c4tiologie und klinische Pr\u00e4sentation\u2002Zuletzt in den Fokus ger\u00fcckt ist die perikardiale Beteiligung im Rahmen einer SARS-CoV-2-Infektion. Zudem werden Perikarditiden nach stattgehabter Corona-Impfung berichtet.<\/jats:p><jats:p>\n          Diagnostik\u2002Zur Diagnosestellung stehen unver\u00e4ndert das EKG sowie die Bildgebung mittels Echokardiografie, Kardio-CT und -MRT im Vordergrund.<\/jats:p><jats:p>\n          Therapie\u2002Als First-Line-Therapie sind weiterhin NSAR und Colchicin vorgesehen; bei Unvertr\u00e4glichkeiten k\u00f6nnen ebenfalls Glukokortikoide (Second Line) gegeben werden. Im Falle von Rezidiven, welche nicht auf diese Therapien ansprechen, kommen intraven\u00f6se Immunglobuline, Anakinra oder Azathioprin (Third Line) zum Einsatz. Die Ultima Ratio stellt die Perikard-Ektomie dar. Die Entwicklung und das Einsetzen von Medikamenten, die sich spezifisch gegen einzelne Komponenten molekularer Signalwege richten, werden in Zukunft immer mehr an Bedeutung erlangen.<\/jats:p>","DOI":"10.1055\/a-1593-9470","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T22:32:13Z","timestamp":1653949933000},"page":"704-710","source":"Crossref","is-referenced-by-count":0,"title":["Was ist neu bei Perikard-Erkrankungen?"],"prefix":"10.1055","volume":"147","author":[{"given":"Dimitar","family":"Divchev","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Kardiologie, Angiologie und Internistische Intensivmedizin, Phillips-Universit\u00e4t Marburg, Universit\u00e4tsklinik Gie\u00dfen und Marburg, Campus Marburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareike","family":"Schnurbus","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Kardiologie, Angiologie und Internistische Intensivmedizin, Phillips-Universit\u00e4t Marburg, Universit\u00e4tsklinik Gie\u00dfen und Marburg, Campus Marburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Schieffer","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Kardiologie, Angiologie und Internistische Intensivmedizin, Phillips-Universit\u00e4t Marburg, Universit\u00e4tsklinik Gie\u00dfen und Marburg, Campus Marburg"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Y Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12181-017-0137-1","article-title":"Kommentar zu den 2015-Leitlinien der Europ\u00e4ischen Gesellschaft f\u00fcr Kardiologie (ESC) zu Perikarderkrankungen","volume":"11","author":"B Maisch","year":"2017","journal-title":"Kardiologe"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2019.11.021","article-title":"Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review","volume":"75","author":"J G Chiabrando","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jamacardio.2020.3557","article-title":"Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"V O Puntmann","year":"2020","journal-title":"JAMA Cardiol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jama.2021.13443","article-title":"Myocarditis and Pericarditis After Vaccination for COVID-19","volume":"326","author":"G A Diaz","year":"2021","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"784.e1","DOI":"10.1016\/j.amjmed.2015.01.040","article-title":"Etiology of Pericarditis in a Prospective Cohort of 1162 Cases","volume":"128","author":"F Gouriet","year":"2015","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(04)15648-1","article-title":"Pericarditis","volume":"363","author":"R W Troughton","year":"2004","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0002-9343(00)00459-9","article-title":"Clinical clues to the causes of large pericardial effusions","volume":"109","author":"J Sagrista-Sauleda","year":"2000","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e007598","DOI":"10.1161\/JAHA.117.007598","article-title":"Etiology and long-term outcome of patients undergoing pericardiocentesis","volume":"6","author":"A Strobbe","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/ejcts\/ezt138","article-title":"Constrictive pericarditis: risks, aetiologies and outcomes after total pericardiectomy: 24 years of experience","volume":"44","author":"G Szab\u00f3","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10554-011-9916-0","article-title":"MR imaging findings in 76 consecutive surgically proven cases of pericardial disease with CT and pathologic correlation","volume":"28","author":"P M Young","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"key":"ref12","first-page":"470","article-title":"Electrocardiogram in acute pericarditis. Distributions of morphologic and axial changes by stages","volume":"33","author":"D H Spodick","year":"1974","journal-title":"Am J Cardiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.echo.2013.06.023","article-title":"American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography","volume":"26","author":"A L Klein","year":"2013","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jcmg.2016.10.020","article-title":"Quantitative Pericardial Delayed Hyperenhancement Informs Clinical Course in Recurrent Pericarditis","volume":"10","author":"A Kumar","year":"2017","journal-title":"J Am Coll Cardiol Img"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10554-011-9916-0","article-title":"MR imaging findings in 76 consecutive surgically proven cases of pericardial disease with CT and pathologic correlation","volume":"28","author":"P M Young","year":"2012","journal-title":"Int J Cardiovasc Imaging"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.iccl.2017.03.002","article-title":"Invasive Hemodynamics of Pericardial Disease","volume":"6","author":"G Athappan","year":"2017","journal-title":"Intervent Cardiol Clin"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11739-021-02639-6","article-title":"Recurrent pericarditis: an update on diagnosis and management","volume":"16","author":"A Andreis","year":"2012","journal-title":"Intern Emerg Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis","volume":"384","author":"A Klein","year":"2021","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00393-020-00925-w","article-title":"Perikarditis im Rahmen rheumatologischer Erkrankungen \u2013 Was der Rheumatologe wissen sollte","volume":"80","author":"M Krusche","year":"2021","journal-title":"Z Rheumatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/molecules26040976","article-title":"NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases","volume":"26","author":"E Mezzaroma","year":"2021","journal-title":"Molecules"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1593-9470.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T01:18:50Z","timestamp":1661476730000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1593-9470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,5,30]]},"published-print":{"date-parts":[[2022,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1593-9470","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]}}}